Advanced search
Publication Cover
Clinical Ophthalmology Volume 11, 2017 - Issue
Submit an article Journal homepage
469
Views
166
CrossRef citations to date
0
Altmetric
Review

Uveal melanoma: epidemiology, etiology, and treatment of primary disease

Benjamin A Krantz1 Division of Hospital Medicine
,
Nikita Dave2 Division of Hematology/Oncology, Columbia University Medical Center
,
Kimberly M Komatsubara2 Division of Hematology/Oncology, Columbia University Medical Center
,
Brian P Marr3 Ophthalmic Oncology Service, Memorial Sloan Kettering Cancer Center;4 Department of Ophthalmology, Weill Cornell Medical College
&
Richard D Carvajal5 Division of Hematology/Oncology, Columbia University Medical Center, New York, NY, USACorrespondence[email protected]
Pages 279-289 | Published online: 31 Jan 2017

Citations (166)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (7)

Brittany Miles, John Moth & James Mackey. (2021) Usefulness of nivolumab plus ipilimumab immunotherapy for metastatic uveal melanoma. Baylor University Medical Center Proceedings 34:1, pages 118-119.
Read now
Sophie Thornton, Helen Kalirai, Karen Aughton & Sarah E. Coupland. (2020) Unpacking the genetic etiology of uveal melanoma. Expert Review of Ophthalmology 15:4, pages 211-220.
Read now
Leonardo Mastropasqua, Roberto Perilli, Rossella D’Aloisio, Lisa Toto, Alessandra Mastropasqua, Simone Donato, Merilda Taraborrelli, Federica Ginestra, Massimo Porta & Agostino Consoli. (2020) Why Miss the Chance? Incidental Findings while Telescreening for Diabetic Retinopathy. Ophthalmic Epidemiology 27:4, pages 237-245.
Read now
Zhaotian Zhang, Yao Ni, Genghang Chen, Yantao Wei, Manjuan Peng & Shaochong Zhang. (2020) Construction of immune-related risk signature for uveal melanoma. Artificial Cells, Nanomedicine, and Biotechnology 48:1, pages 912-919.
Read now
Dewei Peng, Jing Dong, Yunping Zhao, Xiaomei Peng, Jingjing Tang, Xiaoyan Chen, Lihua Wang, Dan-Ning Hu, Peter S Reinach, Jia Qu & Dongsheng Yan. (2019) miR-142-3p suppresses uveal melanoma by targeting CDC25C, TGFβR1, GNAQ, WASL, and RAC1. Cancer Management and Research 11, pages 4729-4742.
Read now
Daniel Putzer, Peter Schullian & Reto Bale. (2019) Locoregional ablative treatment of melanoma metastases. International Journal of Hyperthermia 36:2, pages 59-63.
Read now
Matthew V Fry, James J Augsburger, June Hall & Zélia M Corrêa. (2018) Posterior uveal melanoma in adolescents and children: current perspectives. Clinical Ophthalmology 12, pages 2205-2212.
Read now

Articles from other publishers (159)

Suresh Moolgavkar, Ellen T. Chang & E. Georg Luebeck. (2023) Multistage carcinogenesis: Impact of age, genetic, and environmental factors on the incidence of malignant mesothelioma. Environmental Research 230, pages 114582.
Crossref
B. Fionda, M.M. Pagliara, A.J. Chyrek, B. Guix, R.F.J. O'Day, L.S. Fog, R. Martínez-Monge & L. Tagliaferri. (2023) Ocular Brachytherapy (Interventional Radiotherapy): Preserving the Vision. Clinical Oncology 35:8, pages e445-e452.
Crossref
Alessandra Loda, Stefano Calza, Arianna Giacomini, Cosetta Ravelli, Adwaid Manu Krishna Chandran, Chiara Tobia, Giovanna Tabellini, Silvia Parolini, Francesco Semeraro, Roberto Ronca & Sara Rezzola. (2023) FGF-trapping hampers cancer stem-like cells in uveal melanoma. Cancer Cell International 23:1.
Crossref
Cari Davies, Stephen Lloyd Brown, Peter Fisher, Laura Hope-Stone, Debra Fisher, Andrew Morgan & Mary Gemma Cherry. (2022) Predictors of emotional distress in uveal melanoma survivors: a systematic review. Eye 37:5, pages 907-924.
Crossref
Lucy M. Han, Kar Wan Lee, Gunay Uludag, Michael I. Seider, Armin R. Afshar, Michele M. Bloomer & Melike Pekmezci. (2023) Prognostic Value of BAP1 and Preferentially Expressed Antigen in Melanoma (PRAME) Immunohistochemistry in Uveal Melanomas. Modern Pathology 36:4, pages 100081.
Crossref
Yasaman Arjmand Abbassi, Claudia Le Guin, Norbert Bornfeld, Nikolaos E. Bechrakis, Michael Zeschnigk & Dietmar R. Lohmann. (2022) Analysis of uveal melanomas and paired constitutional DNA for exclusion of a BAP1-tumor predisposition syndrome. Familial Cancer 22:2, pages 193-202.
Crossref
Cinzia Mazzini, Giulio Vicini, Laura Di Leo, Daniela Massi, Stanislao Rizzo & Fabrizio Giansanti. (2023) Anatomical and Functional Outcomes after Endoresection and Adjuvant Ruthenium Brachytherapy for Uveal Melanoma: A Single-Center Experience. Life 13:4, pages 902.
Crossref
Angela Liu, Brenna Hefley, Paulina Escandon, Sarah E. Nicholas & Dimitrios Karamichos. (2023) Salivary Exosomes in Health and Disease: Future Prospects in the Eye. International Journal of Molecular Sciences 24:7, pages 6363.
Crossref
Lingyun Xu, Kexin Liu, Feng Wang & Ying Su. (2023) Cuproptosis and its application in different cancers: an overview. Molecular and Cellular Biochemistry.
Crossref
Aviral Kumar, Sosmitha Girisa, Mohammed S. Alqahtani, Mohamed Abbas, Mangala Hegde, Gautam Sethi & Ajaikumar B. Kunnumakkara. (2023) Targeting Autophagy Using Long Non-Coding RNAs (LncRNAs): New Landscapes in the Arena of Cancer Therapeutics. Cells 12:5, pages 810.
Crossref
Cristina Barbagallo, Michele Stella, Giuseppe Broggi, Andrea Russo, Rosario Caltabiano & Marco Ragusa. (2023) Genetics and RNA Regulation of Uveal Melanoma. Cancers 15:3, pages 775.
Crossref
Kayleigh Slater, Rosa Bosch, Kaelin Francis Smith, Chowdhury Arif Jahangir, Sandra Garcia-Mulero, Arman Rahman, Fiona O’Connell, Josep M. Piulats, Valerie O’Neill, Noel Horgan, Sarah E. Coupland, Jacintha O’Sullivan, William M. Gallagher, Alberto Villanueva & Breandán N. Kennedy. (2023) 1,4-dihydroxy quininib modulates the secretome of uveal melanoma tumour explants and a marker of oxidative phosphorylation in a metastatic xenograft model. Frontiers in Medicine 9.
Crossref
Noha Soliman, Diaa Mamdouh & Aisha Elkordi. (2023) Choroidal Melanoma: A Mini Review. Medicines 10:1, pages 11.
Crossref
Teresa E. Fowler & Diego Espinosa-Heidmann. 2023. Uveitis - Basics, Diagnosis, and Treatment [Working Title]. Uveitis - Basics, Diagnosis, and Treatment [Working Title].
涵 王. (2023) A Bibliographic Study of “Liver-Eye” Related Research—A Correlation Function Analytic Research between Age-Related Macular Degeneration (AMD) and Traditional Chinese Medicine (TCM) Liver Wind Internal Movement Syndrome. Advances in Clinical Medicine 13:04, pages 6342-6350.
Crossref
Joanna Patrycja Wróblewska, Michał Stefan Lach, Marcin Rucinski, Igor Piotrowski, Lukasz Galus, Wiktoria Maria Suchorska, Stephanie Kreis & Andrzej Marszałek. (2022) MiRNAs from serum-derived extracellular vesicles as biomarkers for uveal melanoma progression. Frontiers in Cell and Developmental Biology 10.
Crossref
Hao Chi, Gaoge Peng, Jinyan Yang, Jinhao Zhang, Guobin Song, Xixi Xie, Dorothee Franziska Strohmer, Guichuan Lai, Songyun Zhao, Rui Wang, Fang Yang & Gang Tian. (2022) Machine learning to construct sphingolipid metabolism genes signature to characterize the immune landscape and prognosis of patients with uveal melanoma. Frontiers in Endocrinology 13.
Crossref
Jessica J. Waninger, Leslie A. Fecher, Christopher Lao, Sarah Yentz, Michael D. Green & Hakan Demirci. (2022) Prognostic Hematologic Biomarkers Following Immune Checkpoint Inhibition in Metastatic Uveal Melanoma. Cancers 14:23, pages 5789.
Crossref
Gozde Yazici, Hayyam Kiratli, Gokhan Ozyigit, Sezin Yuce Sari, Aysenur Elmali, Melek Tugce Yilmaz, Irem Koc, Ozge Deliktas, Ekim Gumeler, Mustafa Cengiz & Faruk Zorlu. (2022) Every other day stereotactic radiation therapy for the treatment of uveal melanoma decreases toxicity. Radiotherapy and Oncology 176, pages 39-45.
Crossref
Daniel Fernando Santos-Bustos, Binh Minh Nguyen & Helbert Eduardo Espitia. (2022) Towards automated eye cancer classification via VGG and ResNet networks using transfer learning. Engineering Science and Technology, an International Journal 35, pages 101214.
Crossref
Rodrigo Jorge, Igor Coelho, Gustavo Viani, Amanda Alexia R. Vieira, Fernando Chahud, Daniel G. Abud & Zelia M. Correa. (2022) Melphalan intra-arterial chemotherapy for choroidal melanoma chemoreduction. International Journal of Retina and Vitreous 8:1.
Crossref
Margarete M. Karg, Lukas John, Nasrin Refaian, Christian Buettner, Tanja Rottmar, Jonas Sommer, Barbara Bock, Yazid J. Resheq, Bruce R. Ksander, Ludwig M. Heindl, Andreas Mackensen & Jacobus J. Bosch. (2022) Midkine Promotes Metastasis and Therapeutic Resistance via mTOR/RPS6 in Uveal Melanoma. Molecular Cancer Research 20:8, pages 1320-1336.
Crossref
Svetlana V. Saakyan, Irina V. Svirina, Alexander Ju. Tsygankov, Elena B. Myakoshina, Tatyana N. Kiseleva & Kseniya V. Lugovkina. (2022) Structure of iris neoplasms in children and adolescents. Russian Pediatric Ophthalmology 17:2, pages 21-30.
Crossref
Arshpreet Bassi, Saffire H Krance, Aidan Pucchio, Daiana R Pur, Rafael N Miranda & Tina Felfeli. (2022) The Application of Artificial Intelligence in the Analysis of Biomarkers for Diagnosis and Management of Uveitis and Uveal Melanoma: A Systematic Review. Clinical Ophthalmology Volume 16, pages 2895-2908.
Crossref
Pui Ying Chan, Melissa M. Phillips, Stephen Ellis, Amanda Johnston, Xiaoxing Feng, Amit Arora, Gordon Hay, Victoria M. L. Cohen, Mandeep S. Sagoo, John S. Bomalaski, Michael T. Sheaff & Peter W. Szlosarek. (2022) A Phase 1 study of ADI‐PEG20 (pegargiminase) combined with cisplatin and pemetrexed in ASS1‐negative metastatic uveal melanoma . Pigment Cell & Melanoma Research 35:4, pages 461-470.
Crossref
Nabanita Mukherjee, Chiara R. Dart, Carol M. Amato, Adam Honig-Frand, James R. Lambert, Karoline A. Lambert, William A. Robinson, Richard P. Tobin, Martin D. McCarter, Kasey L. Couts, Mayumi Fujita, David A. Norris & Yiqun G. Shellman. (2022) Expression Differences in BCL2 Family Members between Uveal and Cutaneous Melanomas Account for Varying Sensitivity to BH3 Mimetics. Journal of Investigative Dermatology 142:7, pages 1912-1922.e7.
Crossref
Yihang Fu, Wei Xiao & Yuxiang Mao. (2022) Recent Advances and Challenges in Uveal Melanoma Immunotherapy. Cancers 14:13, pages 3094.
Crossref
Meng Lv, Xinhua Yan & Yuanxing Tu. (2022) A Predictive Web-Based Nomogram for Elderly Patients Newly Diagnosed as Uveal Melanoma: A Population-Based Study. Frontiers in Medicine 9.
Crossref
Meng Xie & Chun Xin. (2022) RASD2 promotes the development and metastasis of uveal melanoma via enhancing glycolysis. Biochemical and Biophysical Research Communications 610, pages 92-98.
Crossref
I. Yu. Zherkо, P. D. Dziameshkо, L. V. Naumenko, I. I. Minailо, E. P. Zhyliayeva, O. A. Hizemava & O. A. Navasel’skaya. (2022) The immediate results of choroidal melanoma treatment using stereotactic radiosurgery. Diagnostic radiology and radiotherapy 13:1, pages 95-102.
Crossref
Anjum Mehmood DhamaniImran Nisar ShaikhSuresh AdvaniSuku SnehaSusrita Bhattacharyya. (2022) Redefining the treatment of metastatic uveal melanoma with immunotherapy – A case report. International Journal of Molecular and Immuno Oncology 7, pages 46-49.
Crossref
Grace B. Phelps, Hannah R. Hagen, Adam Amsterdam & Jacqueline A. Lees. (2022) MITF deficiency accelerates GNAQ-driven uveal melanoma. Proceedings of the National Academy of Sciences 119:19.
Crossref
Zhongyi Fan, Jingjing Duan, Pu Luo, Ling Shao, Qiong Chen, Xiaohua Tan, Lei Zhang & Xiaojie Xu. (2022) SLC25A38 as a novel biomarker for metastasis and clinical outcome in uveal melanoma. Cell Death & Disease 13:4.
Crossref
Alessandra Loda, Marta Turati, Francesco Semeraro, Sara Rezzola & Roberto Ronca. (2022) Exploring the FGF/FGFR System in Ocular Tumors: New Insights and Perspectives. International Journal of Molecular Sciences 23:7, pages 3835.
Crossref
Anna Han, Vivian Chua, Usman Baqai, Timothy J. Purwin, Nelisa Bechtel, Emily Hunter, Manoela Tiago, Erin Seifert, David W. Speicher, Zachary T. Schug, J. William Harbour & Andrew E. Aplin. (2022) Pyruvate dehydrogenase inactivation causes glycolytic phenotype in BAP1 mutant uveal melanoma. Oncogene 41:8, pages 1129-1139.
Crossref
Husvinee Sundaramurthi, Sandra García-Mulero, Valentina Tonelotto, Kayleigh Slater, Simone Marcone, Josep M. Piulats, Ronald William Watson, Desmond J. Tobin, Lasse D. Jensen & Breandán N. Kennedy. (2022) Uveal Melanoma Cell Line Proliferation Is Inhibited by Ricolinostat, a Histone Deacetylase Inhibitor. Cancers 14:3, pages 782.
Crossref
Fei Xia, Zhilong Yu, Aijun Deng & Guohong Gao. (2021) Identification of molecular subtyping system and four-gene prognostic signature with immune-related genes for uveal melanoma. Experimental Biology and Medicine 247:3, pages 246-262.
Crossref
Deqian Kong, Li Li, Huajun Wang, Ke Li & Guangying Zheng. (2022) Immunological significance of survival-related alternative splicing in uveal melanoma. Aging 14:2, pages 811-825.
Crossref
Shanna Dewaele, Louis Delhaye, Boel De Paepe, Eric James de Bony, Jilke De Wilde, Katrien Vanderheyden, Jasper Anckaert, Nurten Yigit, Justine Nuytens, Eveline Vanden Eynde, Joél Smet, Maxime Verschoore, Fariba Nemati, Didier Decaudin, Manuel Rodrigues, Peihua Zhao, Aart Jochemsen, Eleonora Leucci, Jo Vandesompele, Jo Van Dorpe, Jean-Christophe Marine, Rudy Van Coster, Sven Eyckerman & Pieter Mestdagh. (2021) The long non-coding RNA SAMMSON is essential for uveal melanoma cell survival. Oncogene 41:1, pages 15-25.
Crossref
Ahmad Abdel-Aty, Wendy L. Linderman, Ninani Kombo, John Sinard & Renelle Pointdujour-Lim. (2022) Necrotic Uveal Melanoma Mimics Orbital Cellulitis: A Review. Ocular Oncology and Pathology 8:1, pages 1-8.
Crossref
Vivian Chua, Anna Han, Nelisa Bechtel, Timothy J. Purwin, Emily Hunter, Connie Liao, J. William Harbour & Andrew E. Aplin. (2021) The AMP‐dependent kinase pathway is upregulated in BAP1 mutant uveal melanoma . Pigment Cell & Melanoma Research 35:1, pages 78-87.
Crossref
Michael D. Onken, Sarah E. Noda, Kevin M. Kaltenbronn, Cheryl Frankfater, Carol M. Makepeace, Nikki Fettig, Kisha D. Piggott, Philip L. Custer, Joseph E. Ippolito & Kendall J. Blumer. (2022) Oncogenic Gq/11 signaling acutely drives and chronically sustains metabolic reprogramming in uveal melanoma. Journal of Biological Chemistry 298:1, pages 101495.
Crossref
Philipp Jurmeister, Niklas Wrede, Inga Hoffmann, Claudia Vollbrecht, Daniel Heim, Michael Hummel, Peggy Wolkenstein, Ines Koch, Verena Heynol, Wolfgang Daniel Schmitt, Anne Thieme, Daniel Teichmann, Christine Sers, Andreas Deimling, Julia Cara Thierauf, Maximilian Laffert, Frederick Klauschen & David Capper. (2021) Mucosal melanomas of different anatomic sites share a common global DNA methylation profile with cutaneous melanoma but show location‐dependent patterns of genetic and epigenetic alterations . The Journal of Pathology 256:1, pages 61-70.
Crossref
Krzysztof Bilmin, Kamil J. Synoradzki, Anna M. Czarnecka, Mateusz J. Spałek, Tamara Kujawska, Małgorzata Solnik, Piotr Merks, Mario Damiano Toro, Robert Rejdak & Michał Fiedorowicz. (2021) New Perspectives for Eye-Sparing Treatment Strategies in Primary Uveal Melanoma. Cancers 14:1, pages 134.
Crossref
Nuno Jorge Lamas, Arnaud Martel, Sacha Nahon-Estève, Samantha Goffinet, Adam Macocco, Corine Bertolotto, Sandra Lassalle & Paul Hofman. (2021) Prognostic Biomarkers in Uveal Melanoma: The Status Quo, Recent Advances and Future Directions. Cancers 14:1, pages 96.
Crossref
Lu Zhao, Wenwen Xia, Yan Zhang, Peng Zou, Qiwen Zhu & Rong Zhang. (2021) Efficacy and Safety of Immune Checkpoint Blockades in the Treatment of Ocular Melanoma: A Systematic Review and Meta-Analysis. Frontiers in Oncology 11.
Crossref
Mark J. de Lange, Rogier J. Nell & Pieter A. van der Velden. (2021) Scientific and clinical implications of genetic and cellular heterogeneity in uveal melanoma. Molecular Biomedicine 2:1.
Crossref
Anna Tosi, Rocco Cappellesso, Angelo Paolo Dei Tos, Valentina Rossi, Camillo Aliberti, Jacopo Pigozzo, Alessio Fabozzi, Marta Sbaraglia, Stella Blandamura, Paola Del Bianco, Vanna Chiarion-Sileni & Antonio Rosato. (2021) The immune cell landscape of metastatic uveal melanoma correlates with overall survival. Journal of Experimental & Clinical Cancer Research 40:1.
Crossref
Tianyu Wang, Yuanyuan Zhang, Jianhao Bai, Yawen Xue & Qing Peng. (2021) MMP1 and MMP9 are potential prognostic biomarkers and targets for uveal melanoma. BMC Cancer 21:1.
Crossref
Cristina Barbagallo, Chiara Bianca Maria Platania, Filippo Drago, Davide Barbagallo, Cinzia Di Pietro, Michele Purrello, Claudio Bucolo & Marco Ragusa. (2021) Do Extracellular RNAs Provide Insight into Uveal Melanoma Biology?. Cancers 13:23, pages 5919.
Crossref
Corine Bertolotto. (2021) Cutaneous and uveal melanoma: two different cancers in therapeutic needs. Comptes Rendus. Biologies 344:3, pages 219-231.
Crossref
L. V. Navumenko, S. A. Krasny, K. P. Zhylayeva, A. A. Evmenenko & I. Y. Zherko. (2021) ANALYSIS OF METASTASIS-FREE SURVIVAL IN PATIENTS WITH SMALL CHOROID MELANOMA DEPENDING ON THE TYPE OF PRIMARY TUMOR TREATMENT. Siberian journal of oncology 20:5, pages 108-114.
Crossref
Ryota Tanaka, Mizue Terai, Eric Londin & Takami Sato. (2021) The Role of HGF/MET Signaling in Metastatic Uveal Melanoma. Cancers 13:21, pages 5457.
Crossref
Chun Yang, Rui Wang & Pierre Hardy. (2021) Potential of miRNA-Based Nanotherapeutics for Uveal Melanoma. Cancers 13:20, pages 5192.
Crossref
Yong Joon Kim, Myeongjee Lee, Eun Hwa Kim, Inkyung Jung & Christopher Seungkyu Lee. (2021) Coexisting and Second Primary Cancers in Patients with Uveal Melanoma: A 10-Year Nationwide Database Analysis. Journal of Clinical Medicine 10:20, pages 4744.
Crossref
Daniel Branisteanu, Camelia Bogdanici, Daciana Branisteanu, Minela Maranduca, Mihail Zemba, Florian Balta, Catalina Branisteanu & Andreea Moraru. (2021) Uveal melanoma diagnosis and current treatment options (Review). Experimental and Therapeutic Medicine 22:6.
Crossref
Weitao Lin, Aaron B. Beasley, Nima Mesbah Ardakani, Elena Denisenko, Leslie Calapre, Matthew Jones, Benjamin A. Wood, Lydia Warburton, Alistair R. R. Forrest & Elin S. Gray. (2021) Intra- and intertumoral heterogeneity of liver metastases in a patient with uveal melanoma revealed by single-cell RNA sequencing. Molecular Case Studies 7:5, pages a006111.
Crossref
Mario Damiano Toro, Lucia Gozzo, Luciano Tracia, Marco Cicciù, Filippo Drago, Claudio Bucolo, Teresio Avitabile, Robert Rejdak, Katarzyna Nowomiejska, Sandrine Zweifel, Yacoub A. Yousef, Rashed Nazzal & Giovanni Luca Romano. (2021) New Therapeutic Perspectives in the Treatment of Uveal Melanoma: A Systematic Review. Biomedicines 9:10, pages 1311.
Crossref
Ahmed J Naser, Maryam Alkhayat & Abdulhameed H Mahmood. (2021) Localized Choroidal Melanoma Managed by Pars Plana Endoresection, Endodiathermy, and Endolaser. Cureus.
Crossref
Claudia Raluca Mărginean & Alexandra Mihaela Rațiu. (2021) Uveal Tumor with Retinal Detachment – Case Report of a Rare Malignancy. Journal of Interdisciplinary Medicine 6:3, pages 167-170.
Crossref
Malgorzata Gajdzis, Radoslaw Kaczmarek & Pawel Gajdzis. (2021) Novel Prognostic Immunohistochemical Markers in Uveal Melanoma-Literature Review. Cancers 13:16, pages 4031.
Crossref
Courtney C. Oare, Christopher L. Deufel, Jordan McCauley Cutsinger, Tania De La Fuente Herman & Clara Ferreira. (2021) On the importance of quality assurance (QA) for COMS eye plaque Silastic inserts: A guide to measurement methods, typical variations, and an example of how QA intercepted a manufacturing aberration. Journal of Applied Clinical Medical Physics 22:8, pages 72-82.
Crossref
Antonios Revythis, Sidrah Shah, Mikolaj Kutka, Michele Moschetta, Mehmet Akif Ozturk, George Pappas-Gogos, Evangelia Ioannidou, Matin Sheriff, Elie Rassy & Stergios Boussios. (2021) Unraveling the Wide Spectrum of Melanoma Biomarkers. Diagnostics 11:8, pages 1341.
Crossref
Feng Liu-Smith, Chi-Yang Chiu, Daniel L. Johnson, Phillip Winston Miller, Evan S. Glazer, Zhaohui Wu & Matthew W. Wilson. (2021) The Sex Differences in Uveal Melanoma: Potential Roles of EIF1AX, Immune Response and Redox Regulation. Current Oncology 28:4, pages 2801-2811.
Crossref
Ping Hou, Siqi Bao, Dandan Fan, Congcong Yan, Jianzhong Su, Jia Qu & Meng Zhou. (2021) Machine learning-based integrative analysis of methylome and transcriptome identifies novel prognostic DNA methylation signature in uveal melanoma. Briefings in Bioinformatics 22:4.
Crossref
Ilaria Proietti, Nevena Skroza, Luca Filippi, Nicoletta Bernardini, Alessandra Mambrin, Ersilia Tolino, Giovanni Rossi, Anna Marchesiello, Federica Marraffa, Salvatore Volpe, Oreste Bagni & Concetta Potenza. (2021) Long-Term Maintained Response to Selective Internal Radiation Therapy in an Oligometastatic Uveal Melanoma Patient Treated with Concomitant Anti-PD-1 Therapy. Life 11:7, pages 692.
Crossref
Joanna Patrycja Wróblewska, Michał Stefan Lach, Katarzyna Kulcenty, Łukasz Galus, Wiktoria Maria Suchorska, Daniel Rösel, Jan Brábek & Andrzej Marszałek. (2021) The Analysis of Inflammation-Related Proteins in a Cargo of Exosomes Derived from the Serum of Uveal Melanoma Patients Reveals Potential Biomarkers of Disease Progression. Cancers 13:13, pages 3334.
Crossref
Maria Fili, Stefan Seregard & Gustav Stålhammar. (2021) Presenting Symptoms Are Associated with Uveal Melanoma-Related Death. Ophthalmology 128:7, pages 1107-1109.
Crossref
Ana Latorre, Alfonso Latorre, Milagros Castellanos, Nuria Lafuente-Gómez, Ciro Rodriguez Diaz, Alejandra Crespo-Barreda, Mercedes Lecea, Marco Cordani, Pilar Martín-Duque & Álvaro Somoza. (2021) Albumin-based nanostructures for uveal melanoma treatment. Nanomedicine: Nanotechnology, Biology and Medicine 35, pages 102391.
Crossref
Johannes Ludwig, Johannes Haubold, Till-Alexander Heusner, Sebastian Bauer, Jens T. Siveke, Heike Richly, Axel Wetter, Lale Umutlu & Jens M. Theysohn. (2020) Lactate Dehydrogenase Prior to Transarterial Hepatic Chemoperfusion Predicts Survival and Time to Progression in Patients with Uveal Melanoma Liver Metastases. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren 193:06, pages 683-691.
Crossref
Cinja Kaak, Vinodh Kakkassery, Björn O. Scheef, Marco Zschoche, Felix Rommel, Guido Hildebrandt, Steffen Emmert, Christian Junghanß, Rudolf F. Guthoff, Anselm M. Jünemann & Uwe Walter. (2021) Evaluation of Choroidal Melanoma Vascularization by Color Doppler Flow Imaging: An Option for Follow-Up Tumor Control Assessment after CyberKnife®?. Medicina 57:6, pages 553.
Crossref
Johannes M. Ludwig, Johannes Haubold, Sebastian Bauer, Heike Richly, Jens T. Siveke, Julia Wimmer, Lale Umutlu, Benedikt M. Schaarschmidt & Jens M. Theysohn. (2021) Predictive impact of the inflammation-based indices in uveal melanoma liver metastases treated with transarterial hepatic chemoperfusion. Radiology and Oncology 55:3, pages 347-353.
Crossref
Barbora Žajdlíková, Josef Šach, Marta Ježová, Daniela Vysloužilová, Johana Glezgová, Pavel Diblík, Jarmila Heissigerová, Veronika Lazarčíková, Inka Krejčířová, Rudolf Autrata & Daniel Autrata. (2021) Uveal Melanoma In A 15-Year-Old Girl. Case Report. Czech and Slovak Ophthalmology 77:2, pages 94-100.
Crossref
Zenan Lin & Daniela Süsskind. (2021) Exploring the role of BAFF as biomarker in the detection of uveal melanoma metastases. Journal of Cancer Research and Clinical Oncology 147:5, pages 1389-1405.
Crossref
Hai Yang, Min‐Yun Cai, Hua Rong, Li‐Rong Ma & Yue‐Li Xu. (2021) ZNF667‐AS1, a positively regulating MEGF10, inhibits the progression of uveal melanoma by modulating cellular aggressiveness. Journal of Biochemical and Molecular Toxicology 35:5.
Crossref
Melissa Chalada, Charmaine A. Ramlogan-Steel, Bijay P. Dhungel, Christopher J. Layton & Jason C. Steel. (2021) The Impact of Ultraviolet Radiation on the Aetiology and Development of Uveal Melanoma. Cancers 13:7, pages 1700.
Crossref
Mina M. Naguib, Patricia Chévez-Barrios, Silvia Orengo-Nania & Amy C. Schefler. (2021) Locally Invasive Diffuse Iris Ring Melanoma Presenting as Unilateral Severe Glaucoma: Case Report and Review of Molecular Genetics. Case Reports in Oncology 14:1, pages 403-410.
Crossref
Michael D. Onken, Kendall J. Blumer & John A. Cooper. (2021) Uveal melanoma cells use ameboid and mesenchymal mechanisms of cell motility crossing the endothelium. Molecular Biology of the Cell 32:5, pages 413-421.
Crossref
Ortal Zaks, Dimitri Gaber, Keren Ben-Yaakov, Maya Sharvit-Bader, Alexa Goz, Ziv Rotfogel, Shahar Ish-Shalom, Evgeniya Kesler, Ady Yosepovich, Hana Leiba, Martine J. Jager, Arie L. Marcovich & Michal Aharoni-Simon. (2021) In-vivo imaging for assessing tumor growth in mouse models of ocular melanoma. Experimental Eye Research 204, pages 108431.
Crossref
Lili Hao, Jiayang Yin, Hong Yang, Chaoxuan Li, Linxin Zhu, Lian Liu & Jingxiang Zhong. (2021) ALKBH5-mediated m6A demethylation of FOXM1 mRNA promotes progression of uveal melanoma. Aging 13:3, pages 4045-4062.
Crossref
Cinzia Mazzini, Giulia Pieretti, Giulio Vicini, Cristina Nicolosi, Silvia Scoccianti, Maurizio Pertici, Daniela Greto, Isacco Desideri, Lorenzo Bordi, Guido Pecchioli & Gianni Virgili. (2020) Clinical outcomes and secondary glaucoma after gamma-knife radiosurgery and Ruthenium-106 brachytherapy for uveal melanoma: a single institution experience. Melanoma Research 31:1, pages 38-48.
Crossref
Păsărică Mihai Adrian, Dragosloveanu Christiana Diana Maria, Maria Iuliana Gruia, Gabriela Murgoi, Schmitzer Speranţa & Alexandru Grigorescu. (2021) Eye malignant melanoma – the correlation of clinical evolution with biological and immunological parameters. Oncolog-Hematolog.ro 4:57, pages 23.
Crossref
E.B. Myakoshina, I.G. Kulikova, N.V. Balatskaya, L.A. Katargina & S.V. Saakyan. (2021) The role of CXC and CC chemokines in patients with uveal melanoma. Vestnik oftal'mologii 137:4, pages 31.
Crossref
Marlana Orloff. (2021) Clinical Trials in Metastatic Uveal Melanoma: Immunotherapy. Ocular Oncology and Pathology 7:3, pages 168-176.
Crossref
Gretchen M. Alicea & Vito W. Rebecca. (2020) Emerging strategies to treat rare and intractable subtypes of melanoma. Pigment Cell & Melanoma Research 34:1, pages 44-58.
Crossref
Michael D. Onken, Carol M. Makepeace, Kevin M. Kaltenbronn, Joelle Choi, Leonel Hernandez-Aya, Katherine N. Weilbaecher, Kisha D. Piggott, P. Kumar Rao, Carla M. Yuede, Alethia J. Dixon, Patrick Osei-Owusu, John A. Cooper & Kendall J. Blumer. (2021) Targeting primary and metastatic uveal melanoma with a G protein inhibitor. Journal of Biological Chemistry 296, pages 100403.
Crossref
Yamini Attiku & Vikas Khetan. 2021. Ocular Tumors. Ocular Tumors 61 70 .
Asad Javed & Mohammed Milhem. (2020) Role of Natural Killer Cells in Uveal Melanoma. Cancers 12:12, pages 3694.
Crossref
Andra Tilgase, Lita Grīne, Ilze Blāķe, Mārtiņs Borodušķis, Agnija Rasa & Pēteris Alberts. (2020) Effect of oncolytic ECHO-7 virus strain Rigvir on uveal melanoma cell lines. BMC Research Notes 13:1.
Crossref
Takahito Sugase, Bao Q. Lam, Meggie Danielson, Mizue Terai, Andrew E. Aplin, J. Silvio Gutkind & Takami Sato. (2020) Development and optimization of orthotopic liver metastasis xenograft mouse models in uveal melanoma. Journal of Translational Medicine 18:1.
Crossref
Carin F. Gonsalves, Robert D. Adamo & David J. Eschelman. (2020) Locoregional Therapies for the Treatment of Uveal Melanoma Hepatic Metastases. Seminars in Interventional Radiology 37:05, pages 508-517.
Crossref
Beatriz Santos-Buitrago, Gustavo Santos-García & Emiliano Hernández-Galilea. (2020) Artificial intelligence for modeling uveal melanoma. WArtificial Intelligence in Cancer 1:4, pages 51-65.
Crossref
Giuseppe Broggi, Antonio Ieni, Daniela Russo, Silvia Varricchio, Lidia Puzzo, Andrea Russo, Michele Reibaldi, Antonio Longo, Giovanni Tuccari, Stefania Staibano & Rosario Caltabiano. (2020) The Macro-Autophagy-Related Protein Beclin-1 Immunohistochemical Expression Correlates With Tumor Cell Type and Clinical Behavior of Uveal Melanoma. Frontiers in Oncology 10.
Crossref
Huan Luo & Chao Ma. (2020) Identification of prognostic genes in uveal melanoma microenvironment. PLOS ONE 15:11, pages e0242263.
Crossref
Mark R. Middleton, Cheryl McAlpine, Victoria K. Woodcock, Pippa Corrie, Jeffrey R. Infante, Neil M. Steven, Thomas R. Jeffry Evans, Alan Anthoney, Alexander N. Shoushtari, Omid Hamid, Avinash Gupta, Antonella Vardeu, Emma Leach, Revashnee Naidoo, Sarah Stanhope, Sion Lewis, Jacob Hurst, Ita O’Kelly & Mario Sznol. (2020) Tebentafusp, A TCR/Anti-CD3 Bispecific Fusion Protein Targeting gp100, Potently Activated Antitumor Immune Responses in Patients with Metastatic Melanoma. Clinical Cancer Research 26:22, pages 5869-5878.
Crossref
Bryan H. Louie & Razelle Kurzrock. (2020) BAP1: Not just a BRCA1-associated protein. Cancer Treatment Reviews 90, pages 102091.
Crossref
Sarah Tadhg Ferrier & Julia Valdemarin Burnier. (2020) Novel Methylation Patterns Predict Outcome in Uveal Melanoma. Life 10:10, pages 248.
Crossref
Daniela Russo, Rosa Maria Di Crescenzo, Giuseppe Broggi, Francesco Merolla, Francesco Martino, Silvia Varricchio, Gennaro Ilardi, Alessandra Borzillo, Raffaella Carandente, Sara Pignatiello, Massimo Mascolo, Rosario Caltabiano & Stefania Staibano. (2020) Expression of P16INK4a in Uveal Melanoma: New Perspectives. Frontiers in Oncology 10.
Crossref
Thupten Tsering, Alexander Laskaris, Mohamed Abdouh, Prisca Bustamante, Sabrina Parent, Eva Jin, Sarah Tadhg Ferrier, Goffredo Arena & Julia V. Burnier. (2020) Uveal Melanoma-Derived Extracellular Vesicles Display Transforming Potential and Carry Protein Cargo Involved in Metastatic Niche Preparation. Cancers 12:10, pages 2923.
Crossref
Myriam G. Jaarsma-Coes, Marina Marinkovic, Eleftheria Astreinidou, Megan S. Schuurmans, Femke P. Peters, Gregorius P.M. Luyten, Coen R.N. Rasch & Jan-Willem M. Beenakker. (2020) Measuring eye deformation between planning and proton beam therapy position using magnetic resonance imaging. Physics and Imaging in Radiation Oncology 16, pages 33-36.
Crossref
Mutlay Sayan, Swati Mamidanna, Damla Oncel, Imraan Jan, Irina Vergalasova, Joseph Weiner, Nisha Ohri, Banu Acikalin & Anupama Chundury. (2020) Clinical management of uveal melanoma: a comprehensive review with a treatment algorithm. Radiation Oncology Journal 38:3, pages 162-169.
Crossref
Malgorzata Gajdzis, Stamatios Theocharis, Pawel Gajdzis, Nathalie Cassoux, Sophie Gardrat, Piotr Donizy, Jerzy Klijanienko & Radoslaw Kaczmarek. (2020) Ephrin Receptors (Eph): EphA1, EphA5, and EphA7 Expression in Uveal Melanoma—Associations with Clinical Parameters and Patient Survival. Life 10:10, pages 225.
Crossref
Cristina Rodriguez-Vidal, Daniel Fernandez-Diaz, Beatriz Fernandez-Marta, Nerea Lago-Baameiro, María Pardo, Paula Silva, Laura Paniagua, María José Blanco-Teijeiro, Antonio Piñeiro & Manuel Bande. (2020) Treatment of Metastatic Uveal Melanoma: Systematic Review. Cancers 12:9, pages 2557.
Crossref
Chengshou Zhang, Jianghua Hu & Yibo Yu. (2020) CircRNA Is a Rising Star in Researches of Ocular Diseases. Frontiers in Cell and Developmental Biology 8.
Crossref
Siranush Vardanyan, Anton Brosig, Hartmut Merz, Mahdy Ranjbar, Vinodh Kakkassery, Salvatore Grisanti & Aysegül Tura. (2020) Metastasis of Uveal Melanoma with Monosomy-3 Is Associated with a Less Glycogenetic Gene Expression Profile and the Dysregulation of Glycogen Storage. Cancers 12:8, pages 2101.
Crossref
Kevin Yang, Allen S.W. Oak, Radomir M. Slominski, Anna A. Brożyna & Andrzej T. Slominski. (2020) Current Molecular Markers of Melanoma and Treatment Targets. International Journal of Molecular Sciences 21:10, pages 3535.
Crossref
. Czech and Slovak Ophthalmology 76:3.
Crossref
Swadesh K. Das, Santanu Maji, Stephen L. Wechman, Praveen Bhoopathi, Anjan K. Pradhan, Sarmistha Talukdar, Devanand Sarkar, Joseph Landry, Chunqing Guo, Xiang-Yang Wang, Webster K. Cavenee, Luni Emdad & Paul B. Fisher. (2020) MDA-9/Syntenin (SDCBP): Novel gene and therapeutic target for cancer metastasis. Pharmacological Research 155, pages 104695.
Crossref
E. El-Shafaey & Mohamed F. Hamed. (2020) Uveal Melanoma in an Aradi Goat (Capra aegagrus hircus). Journal of Comparative Pathology 177, pages 5-9.
Crossref
Lara Bellini, Thomas Strub, Nadia Habel, Charlotte Pandiani, Sandrine Marchetti, Arnaud Martel, Stéphanie Baillif, Béatrice Bailly-Maitre, Philippe Gual, Robert Ballotti & Corine Bertolotto. (2020) Endoplasmic reticulum stress mediates resistance to BCL-2 inhibitor in uveal melanoma cells. Cell Death Discovery 6:1.
Crossref
Yong Joon Kim, Sung Chul Lee, Sung Eun Kim, Seo Hee Kim, Sang Kyum Kim & Christopher Seungkyu Lee. (2020) YAP Activity is Not Associated with Survival of Uveal Melanoma Patients and Cell Lines. Scientific Reports 10:1.
Crossref
Joanna Patrycja Wróblewska, Michał Stefan Lach, Adam Ustaszewski, Katarzyna Kulcenty, Matthew Ibbs, Inga Jagiełło, Wiktoria Maria Suchorska & Andrzej Marszałek. (2020) The Potential Role of Selected miRNA in Uveal Melanoma Primary Tumors as Early Biomarkers of Disease Progression. Genes 11:3, pages 271.
Crossref
Jackson R. Richards, Jae Hyuk Yoo, Donghan Shin & Shannon J. Odelberg. (2020) Mouse models of uveal melanoma: Strengths, weaknesses, and future directions. Pigment Cell & Melanoma Research 33:2, pages 264-278.
Crossref
Inta Jaunalksne, Linda Brokāne, Donatas Petroška, Agnija Rasa & Pēteris Alberts. (2020) ECHO-7 oncolytic virus Rigvir® in an adjuvant setting for stage I uveal melanoma; A retrospective case report. American Journal of Ophthalmology Case Reports 17, pages 100615.
Crossref
Yufeng Xu, Lixia Lou, Yijie Wang, Qi Miao, Kai Jin, Menglu Chen & Juan Ye. (2020) Epidemiological Study of Uveal Melanoma from US Surveillance, Epidemiology, and End Results Program (2010–2015). Journal of Ophthalmology 2020, pages 1-8.
Crossref
Anja Wessely, Theresa Steeb, Michael Erdmann, Lucie Heinzerling, Julio Vera, Max Schlaak, Carola Berking & Markus Vincent Heppt. (2020) The Role of Immune Checkpoint Blockade in Uveal Melanoma. International Journal of Molecular Sciences 21:3, pages 879.
Crossref
Beatrice Gallo, Rana'aT Al-Jamal, Caroline Thaung & VictoriaM L. Cohen. (2020) Iris extramedullary hematopoiesis in choroidal melanoma. Saudi Journal of Ophthalmology 34:2, pages 82.
Crossref
L. V. Navumenka, L. N. Marchenko, A. A. Dalidovich, S. A. Krasny, P. G. Kiselev, K. P. Zhiliayeva & I. Y. Zherka. (2020) VITREORETINAL SURGERY IN THE COMBINED TREATMENT OF UVEAL MELANOMA. Journal of the Grodno State Medical University 18:3, pages 321-328.
Crossref
Yongyun Li, Jiahao Shi, Jie Yang, Shengfang Ge, Jianming Zhang, Renbing Jia & Xianqun Fan. (2020) Uveal melanoma: progress in molecular biology and therapeutics. Therapeutic Advances in Medical Oncology 12, pages 175883592096585.
Crossref
Meng-Yu Wu, Tzu-Ting Lai, Wan-Ting Liao & Chia-Jung Li. (2020) Clinicopathological and prognostic significance and molecular mechanisms governing uveal melanoma. Therapeutic Advances in Medical Oncology 12, pages 175883592091756.
Crossref
Anja Wessely. (2020) Immuncheckpoint-Blockade – neue Hoffnung für Patienten mit Aderhautmelanom?. Kompass Ophthalmologie 6:4, pages 192-195.
Crossref
Anja Wessely. (2020) Immuncheckpoint-Blockade: Neue Hoffnung für Patienten mit Aderhautmelanom?. Kompass Onkologie 7:3, pages 142-144.
Crossref
Sidharth Puri & Aparna Ramasubramanian. 2020. Intraocular Tumors. Intraocular Tumors 93 102 .
Beatriz Santos-Buitrago & Emiliano Hernández-Galilea. 2020. Practical Applications of Computational Biology and Bioinformatics, 13th International Conference. Practical Applications of Computational Biology and Bioinformatics, 13th International Conference 96 104 .
Mirjana Ziemer, Astrid Monecke & Andrea Forschner. (2019) Molekulares Tumorboard beim MelanomMolecular tumor board in melanoma. Forum 34:6, pages 506-510.
Crossref
Xinshu Xie, Saisai Xie, Changying Xie, Yuanying Fang, Zhifeng Li, Rikang Wang & Wei Jiang. (2019) Pristimerin attenuates cell proliferation of uveal melanoma cells by inhibiting insulin‐like growth factor‐1 receptor and its downstream pathways. Journal of Cellular and Molecular Medicine 23:11, pages 7545-7553.
Crossref
Souri, Wierenga, Mulder, Jochemsen & Jager. (2019) HLA Expression in Uveal Melanoma: An Indicator of Malignancy and a Modifiable Immunological Target. Cancers 11:8, pages 1132.
Crossref
Narges K. Tafreshi, Christopher J. Tichacek, Darpan N. Pandya, Michael L. Doligalski, Mikalai M. Budzevich, HyunJoo Kil, Nikunj B. Bhatt, Nancy D. Kock, Jane L. Messina, Epifanio E. Ruiz, Nella C. Delva, Adam Weaver, William R. Gibbons, David C. Boulware, Nikhil I. Khushalani, Ghassan El-Haddad, Pierre L. Triozzi, Eduardo G. Moros, Mark L. McLaughlin, Thaddeus J. Wadas & David L. Morse. (2019) Melanocortin 1 Receptor–Targeted α-Particle Therapy for Metastatic Uveal Melanoma. Journal of Nuclear Medicine 60:8, pages 1124-1133.
Crossref
Bertil E. Damato, Joseph Dukes, Howard Goodall & Richard D. Carvajal. (2019) Tebentafusp: T Cell Redirection for the Treatment of Metastatic Uveal Melanoma. Cancers 11:7, pages 971.
Crossref
E. B. Souto, A. Zielinska, M. Luis, C. Carbone, C. Martins-Gomes, S. B. Souto & A. M. Silva. (2019) Uveal melanoma: physiopathology and new in situ-specific therapies. Cancer Chemotherapy and Pharmacology 84:1, pages 15-32.
Crossref
Lei Dong, Shuo You, Qing Zhang, Satoru Osuka, Narra S. Devi, Stefan Kaluz, Jalisa H. Ferguson, Hua Yang, Guoliang Chen, Binghe Wang, Hans E. Grossniklaus & Erwin G. Van Meir. (2019) Arylsulfonamide 64B Inhibits Hypoxia/HIF-Induced Expression of c-Met and CXCR4 and Reduces Primary Tumor Growth and Metastasis of Uveal Melanoma. Clinical Cancer Research 25:7, pages 2206-2218.
Crossref
Dong Hyun Jo, Jin Hyoung Kim & Jeong Hun Kim. (2018) Targeting tyrosine kinases for treatment of ocular tumors. Archives of Pharmacal Research 42:4, pages 305-318.
Crossref
K. R. Koch, J. M. Mor, G. Avgitidou, V. Kakkassery, A. C. Rokohl & L. M. Heindl. (2019) Klinisch-echographische Diagnostik bei IristumorenClinico-echographic diagnostics of iris tumors. Der Ophthalmologe 116:4, pages 313-323.
Crossref
Giuseppe Broggi, Giuseppe Musumeci, Lidia Puzzo, Andrea Russo, Michele Reibaldi, Marco Ragusa, Antonio Longo & Rosario Caltabiano. (2019) Immunohistochemical Expression of ABCB5 as a Potential Prognostic Factor in Uveal Melanoma. Applied Sciences 9:7, pages 1316.
Crossref
Paola Savoia, Paolo Fava, Filippo Casoni & Ottavio Cremona. (2019) Targeting the ERK Signaling Pathway in Melanoma. International Journal of Molecular Sciences 20:6, pages 1483.
Crossref
R. M. Lucas, S. Yazar, A. R. Young, M. Norval, F. R. de Gruijl, Y. Takizawa, L. E. Rhodes, C. A. Sinclair & R. E. Neale. (2020) Human health in relation to exposure to solar ultraviolet radiation under changing stratospheric ozone and climate. Photochemical & Photobiological Sciences 18:3, pages 641-680.
Crossref
Yong Cheng, Jing Feng, Xuemei Zhu & Jianhong Liang. (2019) Cytokines concentrations in aqueous humor of eyes with uveal melanoma. Medicine 98:5, pages e14030.
Crossref
Glenda M. Delgado-Ramos, Fridtjof Thomas, Ari VanderWalde, Benjamin King, Matthew Wilson & Arnel M. Pallera. (2019) Risk factors, clinical outcomes, and natural history of uveal melanoma: a single-institution analysis. Medical Oncology 36:2.
Crossref
Swadesh K. Das, Devanand Sarkar, Luni Emdad & Paul B. Fisher. 2019. 137 191 .
Sylvia Lee & Shailender Bhatia. 2019. Immune Checkpoint Inhibitors in Cancer. Immune Checkpoint Inhibitors in Cancer 19 43 .
Luigi Pasini. 2019. Oncogenomics. Oncogenomics 623 642 .
Mariel Angelou Parulan, Shantha Amrith, Stephanie Ming Young, Eric Ting, Bingcheng Wu, Min En Nga & Gangadhara Sundar. 2019. Ocular Adnexal Lesions. Ocular Adnexal Lesions 323 327 .
Qiong Yi & Wen‑Jin Zou. (2018) A novel four‑snoRNA signature for predicting the survival of patients with uveal melanoma. Molecular Medicine Reports.
Crossref
Bradley H. Jacobsen, Christopher Ricks & Roger P. Harrie. (2018) Ocular ultrasound versus MRI in the detection of extrascleral extension in a patient with choroidal melanoma. BMC Ophthalmology 18:1.
Crossref
Melanie Kucherlapati. (2018) Examining transcriptional changes to DNA replication and repair factors over uveal melanoma subtypes. BMC Cancer 18:1.
Crossref
Pallavi Singh, Sagnik Sen, Mousumi Banerjee & Rachna Meel. (2018) Choroidal melanoma masquerading as orbital cellulitis. BMJ Case Reports 11:1, pages e227486.
Crossref
Shalin Shah, Jason J. Luke, Heather A. Jacene, Tianqi Chen, Anita Giobbie-Hurder, Nageatte Ibrahim, Elizabeth L. Buchbinder, David F. McDermott, Keith T. Flaherty, Ryan J. Sullivan, Donald P. Lawrence, Patrick A. Ott & F. Stephen Hodi. (2018) Results from phase II trial of HSP90 inhibitor, STA-9090 (ganetespib), in metastatic uveal melanoma. Melanoma Research 28:6, pages 605-610.
Crossref
Margaret A. Wilczek, Aaron S. Gold, Fiona J. Ehlies & Timothy G. Murray. (2018) Case Report: Importance of B-scan Ultrasonography for the Detection of Choroidal Melanoma. Optometry and Vision Science 95:10, pages 971-974.
Crossref
K. Slater, P. S. Hoo, A. M. Buckley, J. M. Piulats, A. Villanueva, A. Portela & B. N. Kennedy. (2018) Evaluation of oncogenic cysteinyl leukotriene receptor 2 as a therapeutic target for uveal melanoma. Cancer and Metastasis Reviews 37:2-3, pages 335-345.
Crossref
Nikola Hajkova, Jan Hojny, Kristyna Nemejcova, Pavel Dundr, Jan Ulrych, Katerina Jirsova, Johana Glezgova & Ivana Ticha. (2018) Germline mutation in the TP53 gene in uveal melanoma. Scientific Reports 8:1.
Crossref
O. Mohamad, S. Yamada & M. Durante. (2018) Clinical Indications for Carbon Ion Radiotherapy. Clinical Oncology 30:5, pages 317-329.
Crossref
Albert Liao, Pardeep Mittal, David H. Lawson, Jenny J. Yang, Eszter Szalai & Hans E. Grossniklaus. (2018) Radiologic and Histopathologic Correlation of Different Growth Patterns of Metastatic Uveal Melanoma to the Liver. Ophthalmology 125:4, pages 597-605.
Crossref
Brian A. Boone, Samantha Perkins, Rupal Bandi, Ernesto Santos, Kevin McCluskey, David L. Bartlett & James F. Pingpank. (2018) Hepatic artery infusion of melphalan in patients with liver metastases from ocular melanoma. Journal of Surgical Oncology 117:5, pages 940-946.
Crossref
Michelle G. Zhang, John Y. Lee, Ryan A. Gallo, Wensi Tao, David Tse, Ravi Doddapaneni & Daniel Pelaez. (2018) Therapeutic targeting of oncogenic transcription factors by natural products in eye cancer. Pharmacological Research 129, pages 365-374.
Crossref
Daisaku Kimura, Teruyo Kida, Takaki Sato, Masanori Fukumoto, Ryohsuke Kohmoto, Shota Kojima, Hiroshi Mizuno, Hitoshi Sakaguchi, Jun Sugasawa & Tsunehiko Ikeda. (2018) A Case of Retinal Detachment with Unique Optical Coherence Tomography Findings after Gamma Knife® Radiosurgery Treatment for Choroidal Melanoma. Case Reports in Ophthalmology 9:1, pages 23-29.
Crossref
Ken Kageyama, Masahiro Ohara, Kengo Saito, Shinji Ozaki, Mizue Terai, Michael J. Mastrangelo, Paolo Fortina, Andrew E. Aplin & Takami Sato. (2017) Establishment of an orthotopic patient-derived xenograft mouse model using uveal melanoma hepatic metastasis. Journal of Translational Medicine 15:1.
Crossref
Alexander J. Lin, Yuan J. Rao, Sahaja Acharya, Julie Schwarz, Prabakar Kumar Rao & Perry Grigsby. (2017) Patterns of care and outcomes of proton and eye plaque brachytherapy for uveal melanoma: Review of the National Cancer Database. Brachytherapy 16:6, pages 1225-1231.
Crossref
Avinash Gupta, Fabio Gomes & Paul Lorigan. (2017) The role for chemotherapy in the modern management of melanoma. Melanoma Management 4:2, pages 125-136.
Crossref
Zhongyi Fan, Jingjing Duan, Pu Luo, Ling Shao, Qiong Chen, Xiaohua Tan, Lei Zhang & Xiaojie Xu. (2021) SLC25A38 as a Novel Biomarker for Metastasis and Clinical Outcome in Uveal Melanoma. SSRN Electronic Journal.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.